TRIM22 Antibody (HPA003575)

TRIM22 Antibody (HPA003575)


tripartite motif containing 22
100 µl
Available in stock
Alternative names
Species reactivity
Alternative Antibodies
  • Immunohistochemical staining of human rectum shows distinct nuclear and cytoplasmic positivity in glandular cells .
Recommended conditions:
  • Dilution: 1:500 - 1:1000
  • Retrieval method: HIER pH6
Additional IHC Characterization Data
Access additional IHC-data for Anti-TRIM22 on the Human Protein Atlas. View manually annotated IHC-data from 576 human tissue samples of normal and cancer origin as well as duplicate samples from 59 clinical cell samples and cell lines.
  • Lane 1: Marker [kDa] 220, 112, 84, 47, 32, 26, 17
    Lane 2: Human cell line RT-4
Western Blot
Recommended conditions:
  • Dilution: 1:100 - 1:250
Additional WB Characterization Data
Access the Western Blot validation data for Anti-TRIM22 on the Human Protein Atlas. Use the Antigen View to display the antigen location on the target protein for all splice variants.
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence:
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Specific reactivity against target PrEST antigen validated on protein array with 384 randomly selected antigens.
Interspecies Information Highest antigen sequence identity to the following orthologos:
The antibodies are delivered in 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Vial Size 100 µl
Current Lot
0.3 mg/ml
Storage Store at +4°C for short term storage (1-2 days). Long time storage is recommended at -20°C. If stored at lower temperature, aliquot to avoid repeated freezing and thawing. Working dilution samples should be discarded if not used within 12 hours.
Normally shipped at ambient temperature
The antibody solution should be gently mixed before use. Optimal concentrations and conditions for each application should be determined by the user.

Human Protein Atlas

This antibody has been used for staining of 48 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

Petersson J, Lönnbro P, Herr AM, Mörgelin M, Gullberg U, Drott K The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase. Exp Cell Res 2010 Feb 15;316(4):568-79 PubMed ID: 20006605 DOI: 10.1016/j.yexcr.2009.12.007
Singh R, Gaiha G, Werner L, McKim K, Mlisana K, Luban J, Walker BD, Karim SS, Brass AL, Ndung'u T, CAPRISA Acute Infection Study Team Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J Virol 2011 Jan;85(1):208-16 PubMed ID: 20980524 DOI: 10.1128/JVI.01810-10
Carotenuto M, Pedone E, Diana D, de Antonellis P, D?eroski S, Marino N, Navas L, Di Dato V, Scoppettuolo MN, Cimmino F, Correale S, Pirone L, Monti SM, Bruder E, ?enko B, Slavkov I, Pastorino F, Ponzoni M, Schulte JH, Schramm A, Eggert A, Westermann F, Arrigoni G, Accordi B, Basso G, Saviano M, Fattorusso R, Zollo M Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction Sci Rep 31351. Epub 2013/03/01. PubMed ID: 23448979 DOI: 10.1038/srep01351

We are an experienced team of researchers dedicated to helping you with any questions you have regarding our products and their applications.

100 researchers are working within the Human Protein Atlas project. Our Scientific Support Team provides you with answers or guide you to the right people

If you have questions or comments regarding this antibody please contact our Scientific Support:

Are you using our antibodies in an application or in a species we have not yet validated? Go to our Technical Support and Resources page and read about our Explorer Program.


Forgot your email?